| 标题： | 慢阻肺急性加重高风险患者识别与管理中国专家共识 |
| title： | Expert Consensus on identification and management of patients at high risk for acute exacerbation of chronic obstructive pulmonary disease in China |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 管理 |
| field： | Administration |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 呼吸科等相关领域医生 |
| Guide users： | Pulmonary physicians & physician |
| 证据分级方法： | GRADE |
| Evidence grading method： | GRADE |
| 制定单位： | 中华医学会呼吸病学分会慢性阻塞性肺疾病学组 中国医师协会呼吸医师分会慢阻肺病工作委员会 |
| Formulating unit： | COPD group of Chinese Throacic Society，COPD Working Committee of Chinese Medical Doctor Association respiratory physicians section |
| 注册时间： | 2022-10-30 |
| Registration time： | |
| 注册编号： | PREPARE-2022CN688 |
| Registration number： | |
| 指南制订的目的： | 慢阻肺急性加重是加速慢阻肺病疾病进展并导致早期死亡的关键，但当前临床医生对慢阻肺急性加重风险重视尚不足，忽视对慢阻肺急性加重风险进行评估，在预防与管理方面也存在诸多不规范。为提升临床对慢阻肺急性加重风险的识别与管理能力，我国慢阻肺病领域的专家们共同编写了本共识，并就慢阻肺急性加重风险评估的临床意义、慢阻肺急性加重事件的识别与动态监测、急性加重高风险人群的定义以及预防和管理的核心策略，根据最新的研究证据提出了六大推荐意见，希望优化对慢阻肺急性加重高风险患者的临床实践。 |
| Purpose of the guideline： | Acute exacerbation is the key to accelerate the progression of chronic obstructive pulmonary disease and leads to early death. However, clinicians do not pay enough attention to the risk of acute exacerbation, neglect to assess the risk of it, and there are many irregularities in prevention and management. In order to improve the recognition and assessment of acute exacerbation, experts in this field has compiled this consensus. And according to the lasted research evidence, six recommendations about the clinical significance of assessing the risk of acute exacerbation, identification and dynamic monitoring of acute exacerbation events, definition the high risk of acute exacerbation and the core prevention and management strategy has been put forward, hoping to optimize clinical practice for patients at high risk of acute exacerbation. |
